23 December 2022 | News
Manufacturing and marketing approval for an assay kit to identify Amyloid Beta (Aβ) accumulation in the brain
image credit- shutterstock
Sysmex Corporation has received manufacturing and marketing approval in Japan for the HISCL β-Amyloid 1-42 Assay Kit and the HISCL β-Amyloid 1-40 Assay Kit as in vitro diagnostics to measure amyloid beta (Aβ) in the blood.
The product assists in identifying Aβ accumulation in the brain, which is a characteristic of Alzheimer's disease, by measuring Aβ levels in the blood using the company's automated immunoassay system HISCL-5000/HISCL-800.
The company is preparing for market introduction in Japan to give patients access to this minimally invasive and simple test as soon as possible.